[Skip to Navigation]
Observation
January 2018

Vision Loss Secondary to Autologous Adipose Stem Cell Injections: A Rising Problem

Author Affiliations
  • 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
JAMA Ophthalmol. 2018;136(1):97-99. doi:10.1001/jamaophthalmol.2017.5453

Autologous adipose tissue-derived stem cell injections (AASCIs) are a growing trend in the United States.1 Although recent advances with the transplantation of stem cells for Stargardt disease and age-related macular degeneration has spurred promise for future vision-saving therapy, a concurrent surge in for-profit “stem cell” clinics have arisen.1,2 In 2017, Kuriyan et al3 reported the cases of 3 patients who were diagnosed as having traction retinal detachments after AASCI treatment for age-related macular degeneration. Here, we report a similar complication at a different clinic of a patient after receiving intravitreal AASCIs for retinitis pigmentosa, supporting the wider prevalence of such complications.

×